• US CMS retained Aroa Biosurgery's outpatient ECM sheet reimbursement at US$ 127.14 per square centimeter of wound area treated for 2027.
• Final rules published November 4 extend the same rate to non-sheet products in physician offices from January 1, 2027.
• Symphony's rate remains unchanged across hospital outpatient departments, ambulatory surgical centers and physician offices.
• Myriad remains focused on hospital inpatient care, where established reimbursement is unaffected by the outpatient changes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aroa Biosurgery Ltd. published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.